Finland· FI-REL-REL9198
Hyalgan
A hyaluronic acid product containing hyaluronate sodium, registered in Finland by Takeda Oy. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Hyaluronic acid is registered in 7 of 19 countries.
Countries holding a registration under ATC M09AX01 (hyaluronic acid), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Hyaluronic acid · ATC M09AX01
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Japan
- Polandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Hyaluronate sodium
- Manufacturer
- Takeda Oy
- Country
- Finland (FI)
- ATC code
- M09AX01
- ATC class
- Hyaluronic acid
- Defined daily dose
- 3.6 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for hyaluronic acid.
Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hyaluronic acid · interactions on record
6 records
- 6 moderate
Most severe, free to view
- BenzalkoniumD08AJ01moderate
- CetylpyridiniumD08AJ03moderate
- CetylpyridiniumD09AA07moderate
- BenzalkoniumD09AA11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hyaluronic acid in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAactive HA 0.1% eye dropsTriOn Pharma Ltd
- PolandHyalganInPharm Sp. z o.o.
- SwitzerlandIalugen, cremaIBSA Institut Biochimique SA
- United StatesSHINE pH CLEANSINGCH BIO CO., LTD.
- GermanyHyalanPharma Stulln Gmbh
- CanadaHY-50DECHRA LTD
- CzechiaHYALGANFidia Farmaceutici S.p.A., Abano Terme (PD)
- SwedenHyalgan 10 mg/ml Injektionsvätska, lösningEbb Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Hyalgan
- Belgium · Hyalgan
- Bulgaria · Хиалган, Хилора
- Cyprus · Arthryal, Hyalgan
- Czechia · Hyalgan
- Germany · Hyalan, Hyalart
- Spain · Hyalgan
- France · Hyalgan
- Greece · Arthryal, Gonilert
- Hungary · Conheal, Hyalgan
- Italy · Collirio Alfa Occhio Secco, Connettivina
- Luxembourg · Hyalgan
- Poland · Hyalgan
- Portugal · Hyalart
- Romania · Hyalgan
- Slovakia · Hyalgan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb1fe2bb-9192-4371-bcb1-b9fb983284bb GET /v1/drugs/fb1fe2bb-9192-4371-bcb1-b9fb983284bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "3.6",
"form": "injektioneste, liuos",
"route": "Nivelen sisään",
"ddd_unit": "mg",
"strength": null,
"atc_label": "hyaluronihappo",
"ma_number": "12636",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL9198",
"authorised_at": "1997-11-03"
}See everything about hyaluronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.